0001723420-18-000003.txt : 20180711
0001723420-18-000003.hdr.sgml : 20180711
20180711164847
ACCESSION NUMBER: 0001723420-18-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180710
FILED AS OF DATE: 20180711
DATE AS OF CHANGE: 20180711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moscato Robert Jr.
CENTRAL INDEX KEY: 0001723420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-13789
FILM NUMBER: 18949052
MAIL ADDRESS:
STREET 1: 400 PRATT STREET
STREET 2: SUITE 606
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marina Biotech, Inc.
CENTRAL INDEX KEY: 0000737207
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112658569
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17870 CASTLETON STREET
STREET 2: SUITE 250
CITY: CITY OF INDUSTRY
STATE: CA
ZIP: 91748
BUSINESS PHONE: 4259083600
MAIL ADDRESS:
STREET 1: 17870 CASTLETON STREET
STREET 2: SUITE 250
CITY: CITY OF INDUSTRY
STATE: CA
ZIP: 91748
FORMER COMPANY:
FORMER CONFORMED NAME: MDRNA, Inc.
DATE OF NAME CHANGE: 20080610
FORMER COMPANY:
FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-07-10
0
0000737207
Marina Biotech, Inc.
MRNA
0001723420
Moscato Robert Jr.
C/O MARINA BIOTECH, INC.
17870 CASTLETON STREET, SUITE 250
CITY OF INDUSTRY
CA
91748
1
1
0
0
Chief Executive Officer
Options to purchase common stock
0.66
2018-07-10
4
A
0
1500000
0
A
2028-07-10
common stock
1500000
1500000
D
Options to purchase 250,000 shares of common stock are exercisable immediately, options to purchase 250,000 shares of common stock are exercisable on each of July 10, 2019, July 10, 2020 and July 10, 2021, options to purchase 250,000 shares of common stock shall vest on such date (if any) that the Issuer determines that the reporting person has earned the "2018 Revenue Bonus" (as defined in the Employment Agreement dated June 18, 2018 between the Issuer and the reporting person (the "Employment Agreement")), and options to purchase 250,000 shares of common stock shall vest on such date (if any) that the Issuer determines that the reporting person has earned the "2018 Stock Price Bonus" (as defined in the Employment Agreement).
/s/ Robert C. Moscato, Jr.
2018-07-11